Ernexa Therapeutics Inc. (ERNA) Non Operating Income (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Non Operating Income came in at $44000.0 in Q1 2026, up 100.81% YoY from $21911.8 in Q1 2025, and down 99.17% on a QoQ basis from $5.3 million in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Non Operating Income (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 15 years of Non Operating Income data on file, last reported at $44000.0 in Q1 2026.
- Quarterly Non Operating Income rose 100.81% year-over-year to $44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 148.25% YoY) and the FY2025 annual result came in at -$27000.0, up 99.6% from the prior year.
- Non Operating Income slipped to $44000.0 in Q1 2026, from $5.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $19.0 million in Q4 2024 to a low of -$24.3 million in Q3 2024.
- A 5-year average of $87235.3 and a median of -$94000.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 14658.33% — and 2024, when it sank 25786.17%.
- Tracing ERNA's Non Operating Income over 5 years: stood at $288000.0 in 2022, then slumped by 236.11% to -$392000.0 in 2023, then jumped by 4955.1% to $19.0 million in 2024, then sank by 72.08% to $5.3 million in 2025, then tumbled by 99.17% to $44000.0 in 2026.
- The last three Non Operating Income figures came in at $44000.0 (Q1 2026), $5.3 million (Q4 2025), and $759000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 759,000.00 |
| Jun 30, 2025 | -635,000.00 |
| Mar 31, 2025 | -5.46 Mn |
| Dec 31, 2024 | 19.03 Mn |
| Sep 30, 2024 | -24.33 Mn |
| Jun 30, 2024 | -595,000.00 |
| Mar 31, 2024 | -786,000.00 |
| Dec 31, 2023 | -392,000.00 |
| Sep 30, 2023 | -94,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | 288,000.00 |
| Sep 30, 2022 | 993,000.00 |
| Jun 30, 2022 | 10.48 Mn |
| Mar 31, 2022 | -3.08 Mn |
| Dec 31, 2021 | 634,000.00 |
| Sep 30, 2021 | 290,000.00 |